PAULA ALLEN: Open Payments
NPI 1265078570 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 69 payments from 22 companies in 2025. Trend: 2023 $1,733 · 2024 $1,745 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $256 |
| Amgen Inc. | 6 | $192 |
| Abbott Laboratories | 3 | $176 |
| ABBVIE INC. | 12 | $159 |
| AstraZeneca Pharmaceuticals LP | 8 | $153 |
| Lilly USA, LLC | 9 | $129 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $88 |
| PFIZER INC. | 4 | $74 |
| Exact Sciences Corporation | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
Products named: Ozempic, FREESTYLE LIBRE 3, KRYSTEXXA, MOUNJARO, Kerendia, Wegovy, AIRSUPRA, UBRELVY.
Industry payments across SC — which companies pay providers there.
